HIDRADENITIS SUPPURATIVA (HS)

This phase 3 trial tested the drug povorcitinib in 608 people with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps and abscesses. Participants received either the drug or a placebo for 12 weeks, followed by a 42-week extension where eve…

This phase 3 trial tested an oral drug called povorcitinib in 619 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful abscesses. Participants received either the drug or a placebo for 12 weeks, followed by a 42-week extension. The mai…

This study tested whether an artificial intelligence (AI) tool could help primary care doctors diagnose skin conditions more accurately. Nine doctors reviewed 30 images of various skin problems, first giving their own diagnosis and then a final diagnosis after seeing the AI's sug…

This small study tested a combination wound dressing for people with hidradenitis suppurativa (HS) who have non-healing wounds or draining abscesses. The dressing contains methylene blue, gentian violet, and a sheep stomach-derived material. Five adults were followed for 8 weeks …

This study tested whether an artificial intelligence (AI) tool could help doctors diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen doctors, including both general practitioners and dermatologists, looked at 100 skin images. They first ga…

This study examined skin samples from 15 people with hidradenitis suppurativa (HS) and 15 healthy volunteers to measure certain genes and proteins linked to inflammation. The goal was to better understand what causes HS and find possible markers of disease severity. No treatment …